Associations Between APOE Genotypes and Neuropathological Outcomes in Alzheimer's Disease: Insights from the NACC Dataset

These findings suggest that TDP-43 proteinopathy modifies the genetic risk associated with APOE, attenuating the impact of APOE-ε4 while amplifying the protective role of APOE-ε2. APOE-ɛ2 carriers appear to have a protective effect. The presence of TDP-43 proteinopathy may further modify these associations. Future studies should explore the impact of additional genetic and environmental factors on AD neuropathology burden.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_106320
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations Between APOE Genotypes and Neuropathological Outcomes in Alzheimer's Disease: Insights from the NACC Dataset

Alfred Kongnyu NJAMNSHI, Yannick N. Wadop, Xueqiu Jian, Bernard Fongang et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Associations Between APOE Genotypes and Neuropathological Outcomes in Alzheimer's Disease: Insights from the NACC Dataset

Alfred Kongnyu NJAMNSHI, Yannick N. Wadop, Xueqiu Jian, Bernard Fongang, José E Cavazos, Apochi Obed Okwoli, Biniyam Ayele, Rebecca Bernal, Jayandra J. Himali, Alice Nono Djotsa, The African Initiative on Bioinformatics Online Training in Neurodegenerative Diseases (AI‐BOND), Alfred N. Fonteh, Agustin Ruiz, Sudha Seshadri, Margaret E Flanagan, Crystal Wiedner, Muralidharan Sargurupremraj, Nkouonlack Cyrille
article en

Abstract

These findings suggest that TDP-43 proteinopathy modifies the genetic risk associated with APOE, attenuating the impact of APOE-ε4 while amplifying the protective role of APOE-ε2. APOE-ɛ2 carriers appear to have a protective effect. The presence of TDP-43 proteinopathy may further modify these associations. Future studies should explore the impact of additional genetic and environmental factors on AD neuropathology burden.

Alzheimer s & DementiaVol. 21(S1)
Boston University (US), University of Southern California (US), Huntington Medical Research Institutes (US), Michael E. DeBakey VA Medical Center (US), Université de Yaoundé I (CM), National Forensic Sciences University (IN), University of Buea (CM), University of Miami (US), Université de Bordeaux (FR), The University of Texas at San Antonio Health Science Center (US), Baylor College of Medicine (US), Universitat Internacional de Catalunya (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Urology San Antonio (US), Institute for Neurodegenerative Disorders (US), Framingham Heart Study (US), Fundació ACE (ES), Dr. John T. Macdonald Foundation (US), Catholic University of Central Africa (CM), Global Brain Health Institute (US), Addis Ababa University (ET), The University of Texas at San Antonio (US), The University of Texas Health Science Center at Houston (US)
Quality Education
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.